Remove maximize-incident-management-participation
article thumbnail

How To Build an Effective Healthcare Compliance Committee

MedTrainer

In this article, I’ll offer ideas and resources to help you determine who should be involved and strategies for maximizing its impact on maintaining standards and safeguarding patients’ interests. The Centers for Medicare and Medicaid imply that a compliance committee is in place and participates in reporting to the governing board.

article thumbnail

Value-Based Care and its Potential for FQHC and CHC Revenue Streams

MedTrainer

WEBINAR: Maximize Funding Streams Starting With 340B Watch Now What is Value-Based Care? As part of their participation in alternative payment models (APMs ), health providers aim to reduce health care fragmentation and are evaluated on their quality of care and individual health outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The PACE Solution to Increasing Demands for Long-Term Services and Supports in the U.S.

Healthcare Law Blog

As of 2022, there were 148 PACE programs operating 273 centers across 32 states, and serving about 62,000 participants. [7] 9] As such, total federal spending on PACE includes both Medicaid and Medicare spending on the program. 9] As such, total federal spending on PACE includes both Medicaid and Medicare spending on the program.

article thumbnail

Four Best Symplr Alternatives and Competitors

MedTrainer

Symplr software focuses on healthcare governance, risk management, and compliance within the healthcare sector. Their cloud-based solutions aim to enhance healthcare operations via provider data management, workforce management, compliance, quality and safety monitoring, contract, supplier, and spend management.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

In particular, the integration of ICH Guidelines Q9: Quality Risk Management, Q10: Pharmaceutical Quality System, and the inclusion of new technological developments made the revision of Annex 1 imperative. The framework contains parallel provisions for donor selection, quality and safety management and oversight.

FDA 40